Singapore markets closed

Pediatrix Medical Group, Inc. (MD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
9.24-0.16 (-1.70%)
At close: 04:00PM EDT
9.25 +0.01 (+0.11%)
After hours: 06:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 776.40M
Enterprise value 1.30B
Trailing P/E N/A
Forward P/E 7.08
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.38
Price/book (mrq)0.91
Enterprise value/revenue 0.65
Enterprise value/EBITDA 43.51

Trading information

Stock price history

Beta (5Y monthly) 1.58
52-week change 3-34.93%
S&P500 52-week change 322.64%
52-week high 315.06
52-week low 37.70
50-day moving average 39.19
200-day moving average 310.91

Share statistics

Avg vol (3-month) 3679.68k
Avg vol (10-day) 3498.23k
Shares outstanding 584.03M
Implied shares outstanding 684.03M
Float 881.66M
% held by insiders 11.37%
% held by institutions 1102.93%
Shares short (15 Apr 2024) 44.6M
Short ratio (15 Apr 2024) 46.22
Short % of float (15 Apr 2024) 47.79%
Short % of shares outstanding (15 Apr 2024) 45.48%
Shares short (prior month 15 Mar 2024) 44.03M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 320 Dec 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -3.03%
Operating margin (ttm)7.86%

Management effectiveness

Return on assets (ttm)4.32%
Return on equity (ttm)-6.94%

Income statement

Revenue (ttm)1.99B
Revenue per share (ttm)24.26
Quarterly revenue growth (yoy)-3.40%
Gross profit (ttm)N/A
EBITDA 194.02M
Net income avi to common (ttm)-60.41M
Diluted EPS (ttm)0.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)177.74M
Total cash per share (mrq)2.15
Total debt (mrq)701.65M
Total debt/equity (mrq)82.64%
Current ratio (mrq)1.24
Book value per share (mrq)10.27

Cash flow statement

Operating cash flow (ttm)137.32M
Levered free cash flow (ttm)69.2M